SEATTLE, Wash. July 31, 2023 – Anemia affected nearly 2 billion people in 2021, impacting women to a greater degree than men. In a new study covering three decades of global anemia data (1990–2021), a ...
Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia: Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study We identified 421 ...
Please provide your email address to receive an email when new articles are posted on . Many children with sickle cell anemia do not receive guideline-concordant preventive care to reduce their risks ...
Ilene C. Wetiz, MD, professor of clinical medicine at the Keck School of Medicine at the University of Southern California, discusses important points to keep in mind when identifying patients at risk ...
Mutations in FANCX appear to cause a lethal form of Fanconi anemia, a finding that sheds light on unexplained pregnancy loss and offers new avenues for genetic screening. Fanconi anemia is an ...
"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...
Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia: Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study We identified 421 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback